Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Dissociative Disorders

• Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment
• Lamivudine and Plasma Markers of Inflammation in Retinal Detachment
• Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
• A Phase 2, Randomized, Sham-Controlled, Single-Masked, Dose-Ranging, Multi-Center Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Macula-off Rhegmatogenous Retinal Detachment
• A 45 Day, Randomized, Trial of Dextenza in Pediatric Patients Undergoing Retinal Surgeries or Laser Treatments
• Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment With Proliferative Vitreoretinopathy
• Low Dose Ketamine Infusion for Analgesia in the Emergency Department to Reduce Side Effects
• Intravitreal Infliximab for Proliferative Vitreoretinopathy
• Intravitreal Aflibercept for the Prevention of Proliferative Vitreoretinopathy Following Retinal Detachment Repair
• Assessing the Efficacy and Safety of DEXTENZA in Pseudo Phakic Patients Undergoing Gas Bubble Repair and Laser Following Retinal Detachment
• Oral Sedation in Vitreoretinal Surgery
• Dexamethasone Implant for Retinal Detachment in Uveal Melanoma
• A Study to Evaluate the Safety and Tolerability of ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal Detachment
• Ursodeoxycholic Acid for Rhegmatogenous Retinal Detachment
• Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.
• Bevacizumab Against Recurrent Retinal Detachment
• Corneal Endothelial Cell Loss After Pneumatic Retinopexy for the Repair of Primary Rhegmatogenous Retinal Detachment
• Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)
• Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment
• Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy
• Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.
• A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes
• Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment
• On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD)
• Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration
• Ranibizumab for Diabetic Traction Retinal Detachment
• HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
• Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder
• Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments
• Lucentis to Treat Pigment Epithelial Detachment
• Treatment Trial for Psychogenic Nonepileptic Seizures
• Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations
• Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments
• Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA)
• Psychotherapy and Pharmacotherapy in Dissociative Disorders
• Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
• Comparison High-Density Silicone Oils in Retinal Detachment
• A Study in Subjects With Retinal Detachment
• Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment
• Treatments for Psychogenic Nonepileptic Seizures (NES)
• Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment